Hikma Pharmaceutical | HIK - Sales Revenues

Stock Price
1,373.00
Daily Change
-279.00 -16.89%
Monthly
-11.13%
Yearly
-37.08%
Q1 Forecast
1,600.34

Hikma Pharmaceutical reported $829M in Sales Revenues for its fiscal semester ending in June of 2025.





Sales Change Date
Almirall EUR 547.63M 12.83M Dec/2025
argenx SE USD 1.12B 132.91M Dec/2025
AstraZeneca USD 15.5B 313M Dec/2025
Autolus Therapeutics Ltd USD 22.61M 1.71M Sep/2025
Bayer EUR 9.66B 1.08B Sep/2025
Fresenius EUR 5.88B 400M Dec/2025
Galapagos EUR 900.82M 835.52M Dec/2025
Genmab DKK 5.86B 580M Jun/2025
GlaxoSmithKline GBP 8.62B 73M Dec/2025
GRIFOLS EUR 1.87B 20M Sep/2025
Hikma Pharmaceutical USD 829M 758M Jun/2025
Lonza CHF 3.58B 63M Jun/2025
Merck EUR 5.32B 890M Sep/2025
Orion EUR 695.3M 272.1M Dec/2025
Recordati EUR 662M 37.65M Dec/2025
Roche Holding CHF 15.65B 274.5M Dec/2025
Sanofi EUR 11.3B 1.13B Dec/2025
UCB EUR 3.49B 129M Jun/2025